Results 201 to 210 of about 50,845 (250)

A Zosteriform Papular Cutaneous Eruption

open access: yes
JEADV Clinical Practice, Volume 5, Issue 2, Page 728-730, June 2026.
Silvia Borriello   +8 more
wiley   +1 more source

Short‐Term Safety and Adverse Event Risk Profiles for SARS‐CoV‐2 Booster Vaccine Doses in Australian Adults: A Survey Study

open access: yesMedical Journal of Australia, Volume 224, Issue 6, June 2026.
ABSTRACT Objective This study quantifies the short‐term risk profiles of seven severe acute respiratory syndrome coronavirus 2 virus (SARS‐CoV‐2) vaccines—Comirnaty Bivalent BA.1, Comirnaty Bivalent BA.4‐5, Comirnaty XBB.1.5, Spikevax Bivalent BA.1, Spikevax Bivalent BA.4‐5, Spikevax XBB.1.5 and Nuvaxovid—administered as booster doses in Australia ...
Evelyn Tay   +9 more
wiley   +1 more source

Deviated Uvula Resulting From Herpes Zoster Infection: A Case Report. [PDF]

open access: yesCureus
Gowda Venkatesha RR   +4 more
europepmc   +1 more source

Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. [PDF]

open access: yesLancet Neurol
Pomirchy M   +4 more
europepmc   +1 more source

Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors. [PDF]

open access: yesClin Transl Sci
Mandecka A   +7 more
europepmc   +1 more source

Recombinant zoster vaccine induces superior immunogenicity compared with live varicella vaccine in allogeneic haematopoietic stem cell transplantation recipients

open access: yes
British Journal of Haematology, Volume 208, Issue 6, Page 2288-2292, June 2026.
Takaaki Ono   +9 more
wiley   +1 more source

Clinical Management of Herpes Zoster Complicated by MRSA Infection. [PDF]

open access: yesClin Cosmet Investig Dermatol
Chen X, Yu Q, Chang D, Sun L.
europepmc   +1 more source

Home - About - Disclaimer - Privacy